In today’s briefing:
- S&P/ASX Index Rebalance Preview: Moving the Right Way
- Weekly Deals Digest (23 Oct) – Link, Nearmap, Pushpay, Tyro, Singapore Medical, DTAC/True, Blibli
S&P/ASX Index Rebalance Preview: Moving the Right Way
- We see one potential change for the S&P/ASX 50 Index and two potential changes for the S&P/ASX 200 at the December rebalance, though some stocks are close to the cutoffs.
- The potential passive buying on the S&P/ASX 200 (AS51 INDEX) adds will exceed 11 days of ADV while the impact on the other stocks ranges from 1.5-4 days of ADV.
- Most stocks have been moving the right way and there will be pre-positions built up on some of the stocks. Shorts have been active on a few names too.
Weekly Deals Digest (23 Oct) – Link, Nearmap, Pushpay, Tyro, Singapore Medical, DTAC/True, Blibli
- A weekly summary of key developments across ECM and Event-Driven names tracked by us across Hong Kong, Australia, New Zealand, Singapore, Indonesia, Malaysia, Thailand, Korea, India and Chinese ADRs.
- ECM developments – Giant Biogene Holding (GBH HK) will launch a US$500 million HKEx IPO this week. Blibli (1437710D IJ) has launched an IDR8.2 trillion (US$530 million) Indonesian IPO.
- Event-Driven developments Link Administration (LNK AU), Nearmap Ltd (NEA AU), Pushpay Holdings (PPH NZ), Tyro Payments (TYR AU), China Vast Industrial Urban Development (6166 HK), Singapore Medical (SMG SP), DTAC/True.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
